managing infectious hazards

23
OpenWHO.org 0 ©WHO2017 Introduction to Cholera Managing Infectious Hazards

Upload: others

Post on 05-Apr-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

OpenWHO.org 0 ©WHO2017

Introduction to Cholera

Managing Infectious Hazards

OpenWHO.org 1 ©WHO2017

Learning objectives

Describe the case definition and alerts for cholera

Describe main transmission routes

List the key preventive actions

Explain how cholera control is multisectoral

OpenWHO.org 2 ©WHO2017

The disease

Cholera is caused by the bacterium Vibrio cholerae.

It causes diarrhoea that can lead to severe dehydration and death in people of all ages.

Untreated, the case fatality can be as high as 50%.

80% of all infected cases will only have mild or no symptoms at all.

OpenWHO.org 3 ©WHO2017

History

Cholera can cause explosive, widespread epidemics.

Humans carry and spread the disease globally. We are currently in the 7th pandemic. Cholera arrived in Africa in 1971.

OpenWHO.org 4 ©WHO2017

Epidemiology

Transmission via faeco-oral route, contaminated water and food

There are three epidemiological profiles:

Epidemic

Humanitarian crises

Endemic

OpenWHO.org 5 ©WHO2017

Cholera in 2016

South Sudan: 4401 cases,

81 deaths in 2016

OpenWHO.org 6 ©WHO2017

Signs and symptoms

Acute watery diarrhoea with or without vomiting

Dehydration

May also cause hypoglycaemia, hypokalaemia

High risk of fetal loss in pregnant women with cholera (aggressive rehydration current best practice)

OpenWHO.org 7 ©WHO2017

Diagnosis and treatment

Clinical; action can begin

Rapid diagnostic tests to reinforce suspicion of epidemic

Stool culture for confirmation

Polymerase Chain Reaction (PCR) for confirmation

Diagnosis:

OpenWHO.org 8 ©WHO2017

Diagnosis and treatment

No or some signs of dehydration

Rehydrate with Oral Rehydration Salts (ORS)

Severe dehydration

IV rehydration with Ringer’s Lactate.

Antibiotics will help reduce severity and duration of disease

Treatment

OpenWHO.org 9 ©WHO2017

Prevention

Provide access to clean water

and sanitation

Adopt hand washing and other

protective hygiene practices

Engage communities

Provide treatment structures and

services

OpenWHO.org 10 ©WHO2017

Vaccination

Oral Cholera Vaccine (OCV)

Shanchol™ and Euvichol®

1 or 2 doses of vaccine given to

at risk populations above age 1

Protection approximately 80% at

6 months, 65% at 3 years

Longer duration of protection with

2 doses

OpenWHO.org 11 ©WHO2017

Accessing vaccine

Global OCV Stockpile to facilitate access to vaccine

For emergencies (outbreak response and humanitarian crises) vaccine available via the International Coordinating Group (ICG)

For integration in control programme for endemic areas vaccine available via the Global Task Force on Cholera Control (GTFCC) OCV working group

OpenWHO.org 12 ©WHO2017 12

Case definitions

a patient aged 5 years or more presenting with acute watery diarrhoea (AWD) and severe dehydration or dies from AWD

Non-endemic area

any patient aged 2 years or more presenting with AWD or dies from AWD

any patient presenting with AWD or dies from AWD

Endemic areas Epidemic area

Note: children under 5 are

susceptible to cholera and

must be treated accordingly

OpenWHO.org 13 ©WHO2017

Alerts

A death from AWD in a patient aged 5 years or more

A positive rapid diagnostic test

Alerts

OpenWHO.org 14 ©WHO2017

Alerts

A cluster of cases of AWD in patients aged 5 years or more in the same week and from the same area

A doubling of cases of AWD in patients aged 5 years or more compared to the previous week, for two consecutive weeks, in the same geographic area

Alerts

Note: in endemic areas, the

age limit used is 2 years

OpenWHO.org 15 ©WHO2017

Preparedness in identified high risk areas with multisectoral plans using measurable indicators including: surveillance (epidemiological and laboratory), case management, WaSH and vaccination

Rapidity and coordination of multisectoral response

Prevention and control

OpenWHO.org 16 ©WHO2017

Need for analysis of data and anticipation of spread of epidemics

Laboratory capacity for confirmation is weak in many countries and should be reinforced

Key concerns

OpenWHO.org 17 ©WHO2017

WHO technical support and recommendations

Cholera Coordination Mechanism (CCM) is providing a coordinated effort from everyone in emergencies to control cholera.

The Global Taskforce for Cholera Control (GTFCC) is providing a multisectoral platform for coordination and guidance for cholera control.

OpenWHO.org 18 ©WHO2017

WHO technical support and recommendations

New OCV Strategic Advisory Group of Experts on Immunization (SAGE) recommendations expected later this year

New Global WHO Strategy in development looking beyond outbreak response to long term cholera control

OpenWHO.org 19 ©WHO2017

WHO global strategy for cholera control

Eliminate predictable cholera epidemics

Respond to unpredictable epidemics

Reduce the magnitude and severity of cholera during humanitarian crisis

OpenWHO.org 20 ©WHO2017

WHO global strategy for cholera control

Cholera occurrence can be predicted in many settings

Be «pre-emptive»

Cholera is unevenly distributed

Focus on «hot spots»

The long term solution for cholera control is not in the health sector

Be multisectoral

Use OCV for large scale

Immediate impact

Trigger mechanism for long term control

OpenWHO.org 21 ©WHO2017

Research and development

Areas of research on OCV, 1 vs 2 dose regimens, dose spacing and out of cold chain use

Continued work on WaSH practices e.g. reduction of transmission in high risk households

Moving from response to control: identifying best practices, strategies

OpenWHO.org 22 ©WHO2017

Key contacts

Vincent Sodjinou: [email protected] (AFRO Focal Point)

Dominique Legros: [email protected] (Focal point)

David Olson: [email protected] (CCM and Outbreaks)

Lorenzo Pezzoli: [email protected] (OCV)

Kate Alberti: [email protected] (Capacity building)

Johanna Fihman: [email protected] or [email protected]

Photo credits:

WHO/C. Black; WHO/AMRO; WHO/E. Soteras Jalil; WHO/F. Thompson; WHO/L. Pezzoli